SHSE:603207 (China)
Â
Ordinary Shares - Class A
Â¥
21.87
+0.37 (+1.72%)
Jul 27
Business Description
Shanghai Xiao Fang Pharmaceutical Co Ltd
ISIN : CNE1000078H1
Share Class Description:
SHSE:603207: Ordinary Shares - Class ATotal Employee Number:
529Compare
Compare
Traded in other countries / regions
603207.China Index Membership
SSE Composite Index IPO Date
2024-08-26Description
Shanghai Xiao Fang Pharmaceutical Co Ltd is engaged in Research and development, production and sales of topical medicines.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 83.96 | |||||
Equity-to-Asset | 0.91 | |||||
Debt-to-Equity | 0.01 | |||||
Debt-to-EBITDA | 0.03 | |||||
Interest Coverage | 8493.39 | |||||
Piotroski F-Score | N/A/9 | |||||
Altman Z-Score | 20.95 | |||||
Beneish M-Score | -1.97 | |||||
WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -5 | |||||
3-Year EBITDA Growth Rate | -4.6 | |||||
3-Year EPS without NRI Growth Rate | -4.3 | |||||
3-Year FCF Growth Rate | 1.7 | |||||
3-Year Book Growth Rate | 29.9 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 21.63 | |||||
9-Day RSI | 31.85 | |||||
14-Day RSI | 36.86 | |||||
3-1 Month Momentum % | -15.98 | |||||
6-1 Month Momentum % | -25.67 | |||||
12-1 Month Momentum % | -29.27 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 7.97 | |||||
Quick Ratio | 7.42 | |||||
Cash Ratio | 5.84 | |||||
Days Inventory | 100.11 | |||||
Days Sales Outstanding | 77.99 | |||||
Days Payable | 62.28 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 4.9 | |||||
Dividend Payout Ratio | 1.73 | |||||
Forward Dividend Yield % | 4.9 | |||||
5-Year Yield-on-Cost % | 4.9 | |||||
3-Year Average Share Buyback Ratio | -10.2 | |||||
Shareholder Yield % | 4.92 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 63.8 | |||||
Operating Margin % | 43.89 | |||||
Net Margin % | 37.58 | |||||
EBITDA Margin % | 43.71 | |||||
FCF Margin % | 13.03 | |||||
OCF Margin % | 28.22 | |||||
ROE % | 17.84 | |||||
ROA % | 15.68 | |||||
ROIC % | 47.25 | |||||
3-Year ROIIC % | 13.25 | |||||
ROC (Joel Greenblatt) % | 60.36 | |||||
ROCE % | 20.75 | |||||
Years of Profitability over Past 10-Year | 7 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 17.36 | |||||
PE Ratio without NRI | 17.19 | |||||
Price-to-Owner-Earnings | 16.3 | |||||
PEG Ratio | 7.16 | |||||
PS Ratio | 6.51 | |||||
PB Ratio | 3.06 | |||||
Price-to-Tangible-Book | 3.12 | |||||
Price-to-Free-Cash-Flow | 50.15 | |||||
Price-to-Operating-Cash-Flow | 23.09 | |||||
EV-to-EBIT | 12.14 | |||||
EV-to-EBITDA | 12.14 | |||||
EV-to-Revenue | 5.31 | |||||
EV-to-FCF | 40.71 | |||||
Price-to-Graham-Number | 1.54 | |||||
| Price-to-Net-Current-Asset-Value | 4.56 | |||||
| Price-to-Net-Cash | 6.57 | |||||
Earnings Yield (Greenblatt) % | 8.24 | |||||
FCF Yield % | 2.01 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Shanghai Xiao Fang Pharmaceutical Co Ltd Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 541.903 | ||
| EPS (TTM) (Â¥) | 1.26 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 26.39 | ||
| 14-Day RSI | 36.86 | ||
| 14-Day ATR (Â¥) | 0.912409 | ||
| 20-Day SMA (Â¥) | 23.1005 | ||
| 12-1 Month Momentum % | -29.27 | ||
| 52-Week Range (Â¥) | 21.31 - 39.47 | ||
| Shares Outstanding (Mil) | 160.67 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Shanghai Xiao Fang Pharmaceutical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Shanghai Xiao Fang Pharmaceutical Co Ltd Stock Events
| Event | Date | Price (Â¥) | ||
|---|---|---|---|---|
| CNY 0.370000 Cash Dividend | 2026-07-03 | 23.61 (+0.98%) | ||
| CNY 0.700000 Cash Dividend | 2025-10-20 | 33.48 (-1.18%) | ||
| CNY 1.500000 Cash Dividend | 2025-06-10 | 31.14 (+0.84%) |
Show
Entries
Shanghai Xiao Fang Pharmaceutical Co Ltd Frequently Asked Questions
What is Shanghai Xiao Fang Pharmaceutical Co Ltd(SHSE:603207)'s stock price today?
The current price of SHSE:603207 is ¥21.87. The 52 week high of SHSE:603207 is ¥39.47 and 52 week low is ¥21.31.
When is next earnings date of Shanghai Xiao Fang Pharmaceutical Co Ltd(SHSE:603207)?
The next earnings date of Shanghai Xiao Fang Pharmaceutical Co Ltd(SHSE:603207) is .
Does Shanghai Xiao Fang Pharmaceutical Co Ltd(SHSE:603207) pay dividends? If so, how much?
The Dividend Yield %  of Shanghai Xiao Fang Pharmaceutical Co Ltd(SHSE:603207) is 4.9% (As of Today), Highest Dividend Payout Ratio of Shanghai Xiao Fang Pharmaceutical Co Ltd(SHSE:603207) was 1.73. The lowest was 1.71. And the median was 1.71. The  Forward Dividend Yield % of Shanghai Xiao Fang Pharmaceutical Co Ltd(SHSE:603207) is 4.9%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Shanghai Xiao Fang Pharmaceutical Co Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers